Dr. Cutler received his MD from McGill University, Montreal, Canada. He
subsequently received his MPH from the Harvard school of Public Health. He completed postgraduate training in Internal Medicine at Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he currently is a member of the Hematologic Malignancies staff.

Dr. Cutler is a Director of the Adult Cell Transplantation Program, Director of Clinical
Research for Stem Cell Transplantation and Director of the Stem Cell Transplantation
Survivorship Program. He also works as an Associate Professor of Medicine at Harvard Medical School.

Dr. Cutler received his MD from McGill University, Montreal, Canada. He subsequently received his MPH from the Harvard school of Public Health. He completed postgraduate training in Internal Medicine at Royal Victoria Hospital, Montreal, followed by a fellowship in Hematology/Oncology at DFCI. In 2002, he joined DFCI, where he currently is a member of the Hematologic Malignancies staff.
Dr. Cutler is a Director of the Adult Cell Transplantation Program, Director of Clinical Research for Stem Cell Transplantation and Director of the Stem Cell Transplantation Survivorship Program. He also works as an Associate Professor of Medicine at Harvard Medical School.

Adam Jones, Meghan Ottolini (Mego), and producer/brand personality Christian Arcand host ‘Jones and Mego’ weekdays from 2 p.m. - 6 p.m. on WEEI. Jones joined WEEI in January of 2023 from 98.5 The Sports Hub in Boston, where he hosted the station’s night show since 2013 and co-hosted “The Dan Shaughnessy Show” from 2009-10. Ottolini joined WEEI as a part-time host in 2021 before becoming a full-time addition to afternoon drive in 2022. She previously spent five years as a reporter with the Boston Herald and as a co-host of ‘Quick Slants’ on NBC Sports Boston. Arcand, born and raised in Boston’s North End, is in his second stint at WEEI, rejoining the station in November of 2022 after a five-year run with The Sports Hub. 

Adam Jones, Meghan Ottolini (Mego), and producer/brand personality Christian Arcand host ‘Jones and Mego’ weekdays from 2 p.m. - 6 p.m. on WEEI. Jones joined WEEI in January of 2023 from 98.5 The Sports Hub in Boston, where he hosted the station’s night show since 2013 and co-hosted “The Dan Shaughnessy Show” from 2009-10. Ottolini joined WEEI as a part-time host in 2021 before becoming a full-time addition to afternoon drive in 2022. She previously spent five years as a reporter with the Boston Herald and as a co-host of ‘Quick Slants’ on NBC Sports Boston. Arcand, born and raised in Boston’s North End, is in his second stint at WEEI, rejoining the station in November of 2022 after a five-year run with The Sports Hub.

Jones & Mego

Jones & Mego Latest Highlights

WEEI Latest Audio

WEEI 93.7 FM Latest Audio

Corey Cutler, MD, MPH, Director of Adult Cell Transplantation Program, Clinical Research for Stem Cell Transplantation and the Stem Cell Transplantation Survivorship Program, Myeloma Physician, Dana-Farber

In early 2020, it became difficult for Clinton to eat. It was during the pandemic
and much harder at the time to see a doctor, so it took a while before he was able to get checked out. In January 2021, Clinton was diagnosed with esophageal cancer that metastasized into his lungs.

His treatment included six months on a feeding tube, chemotherapy and radiation
treatments. In summer 2021, he received an esophagectomy and now comes in for
chemotherapy every other week. He will continue these sessions for the foreseeable
future.

The American Cancer Society estimates that there will be about 22,370 new
esophageal cancer cases diagnosed (17,690 in men and 4,680 in women) in 2024. Esophageal cancer is more common among men than among women. The
lifetime risk of esophageal cancer in the United States is about 1 in 127 in men and
about 1 in 434 in women.

In early 2020, it became difficult for Clinton to eat. It was during the pandemic and much harder at the time to see a doctor, so it took a while before he was able to get checked out. In January 2021, Clinton was diagnosed with esophageal cancer that metastasized into his lungs.
His treatment included six months on a feeding tube, chemotherapy and radiation treatments. In summer 2021, he received an esophagectomy and now comes in for chemotherapy every other week. He will continue these sessions for the foreseeable future.
The American Cancer Society estimates that there will be about 22,370 new esophageal cancer cases diagnosed (17,690 in men and 4,680 in women) in 2024. Esophageal cancer is more common among men than among women. The lifetime risk of esophageal cancer in the United States is about 1 in 127 in men and about 1 in 434 in women.

Clinton Clark III, 33, esophageal cancer, Bellingham

Red Sox legend and Hall of Famer Carlton Fisk talks about the long-time support he has given to the Jimmy Fund and how Fenway has changed since his playing days.

Red Sox legend and Hall of Famer Carlton Fisk talks about the long-time support he has given to the Jimmy Fund and how Fenway has changed since his playing days.

Carlton Fisk is forever grateful for the Red Sox

Dr. Hartley-Brown's clinical area of focus is treating patients with Multiple
Myeloma. This is an incurable blood cancer, that affects African Americans more
prevalently than other ethnic populations. She also practices clinical research, mainly in the relapsed refractory myeloma disease setting. Dr. Hartley-Brown actively participates as a principal investigator in clinical trials within the Alliance for Clinical Trials, investigator-initiated and investigator sponsored trials. Her area of interest in clinical trials includes use of immunotherapies and targeted therapies, such as
bispecific/tri-specific antibodies, antibody-drug conjugates and modern immune
modulating drugs (ex. cereblon modulators).

Dr. Hartley-Brown's clinical area of focus is treating patients with Multiple Myeloma. This is an incurable blood cancer, that affects African Americans more prevalently than other ethnic populations. She also practices clinical research, mainly in the relapsed refractory myeloma disease setting. Dr. Hartley-Brown actively participates as a principal investigator in clinical trials within the Alliance for Clinical Trials, investigator-initiated and investigator sponsored trials. Her area of interest in clinical trials includes use of immunotherapies and targeted therapies, such as bispecific/tri-specific antibodies, antibody-drug conjugates and modern immune modulating drugs (ex. cereblon modulators).

Corey Cutler, MD, MPH, Director of Adult Cell Transplantation Program, Clinical Research for Stem Cell Transplantation and the Stem Cell Transplantation Survivorship Program, Myeloma Physician, Dana-Farber

In 3 playlist(s)

Jones & Mego

Social links

Follow podcast

Recent clips